We provide a new recombinant antibody specific to the influenza B nucleoprotein (np). This antibody is produced in vitro using a proprietary expression platform. Reactivity of the antibody has been tested using the following influenza B strains;
B/Tokyo/53/99, B/Victoria/504/00, B/Malaysia/2506/04, B/Florida/07/04 and B/Florida/04/06

Results are shown in the graph below.

Specificity of the antibody has been tested using the viruses listed below. R2/3 cross-reacted with none of them.

Influenza A(H1N1)/Taiwan/1/86, Influenza A(H1N1)/Beijing/262/95, A(H1N1)/New Caledonia/20/99, Influenza A(H1N1)/Solomon Islands/03/06, Influenza A(H3N2)/Shangdong/9/93,  Influenza A(H3N2)/ Panama/2007/99,  Influenza A(H3N2)/Kiev/301/94,  Influenza A(H3N2)/Wisconsin/67/05,  Influenza A(H3N2)/ Brisbane/10/07, Parainfluenza Virus, Type 1, Parainfluenza Virus, Type 2, Parainfluenza Virus, Type 3, Adenovirus, type 6 and  Respiratory Syncytial Virus,

Products

Antibodies

Cat.#                              Product name
RIF17, MAb R2/3            Monoclonal mouse anti-influenza virus B group antigen, NEW

Antigens

Cat.#                              Product name
8IN75-2                          Influenza B virus-2
8IN75-3                          Influenza B virus-3
8IN75-4                          Influenza B virus-4
8IN75-5                          Influenza B virus-5
8IN75-6                          Influenza B virus-6

You may also be interested in these products

3IF18             Monoclonal mouse anti-influenza virus B group antigen
3BH9             Monoclonal mouse anti-influenza B haemagglutinin
3BM17           Monoclonal mouse anti-influenza B Matrix protein M1

New Infectious Diseases brochure

Download the Infectious Diseases brochure from the link below
Infectious Diseases Brochure